14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
DGICB vs ROOT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, DGICB (DGICB) captures the overall head-to-head institutional edge over Root, Inc. (ROOT) on higher Unified Composite conviction (30.8/100 SELL vs. 51.2/100 HOLD) after splitting the core matrix 5–5 (led by Valuation Multiples, Profitability & Quality), while ROOT wins 4–2 across the 6-pillar growth and valuation breakdown. DGICB trades at $28.55 (14.4x Forward P/E, 9.0% operating margin) versus ROOT at $45.19 (16.0x Forward P/E, 6.7% operating margin).
Composite vs. Pillar Nuance: While ROOT currently prints a higher short-term Unified Composite Score (51.2/100 HOLD vs. DGICB 30.8/100 SELL), DGICB captures the overall institutional head-to-head verdict (5–5 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (9.0% vs. 6.7% operating margin) and revenue trajectory (-3.4% vs. -1.7% YoY).
Technical & Structure Timing Caution: DGICB trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 66.6); meanwhile ROOT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 41.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DGICB vs ROOT. Trailing 12-month operating profitability (DGICB 9.0% vs ROOT 6.7%) and valuation multiples (DGICB 14.4x vs ROOT 16.0x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Insurance - Property & Casualty value chain with $666.5M market capitalization and 6.7% operating margin.
OpEx & R&D Reinvestment32.7% of Rev ($510M)
90D Engineering Disclosures0 Published
Investor FAQ DGICB vs ROOT Key Questions & Quantitative Answers
As of Nov 16, 2026, DGICB (DGICB) captures the overall head-to-head institutional edge over Root, Inc. (ROOT) on higher Unified Composite conviction (30.8/100 SELL vs. 51.2/100 HOLD) after splitting the core matrix 5–5 (led by Valuation Multiples, Profitability & Quality), while ROOT wins 4–2 across the 6-pillar growth and valuation breakdown. DGICB trades at $28.55 (14.4x Forward P/E, 9.0% operating margin) versus ROOT at $45.19 (16.0x Forward P/E, 6.7% operating margin). Composite vs. Pillar Nuance: While ROOT currently prints a higher short-term Unified Composite Score (51.2/100 HOLD vs. DGICB 30.8/100 SELL), DGICB captures the overall institutional head-to-head verdict (5–5 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (9.0% vs. 6.7% operating margin) and revenue trajectory (-3.4% vs. -1.7% YoY). Technical & Structure Timing Caution: DGICB trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 66.6); meanwhile ROOT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 41.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ROOT leads the Growth & Scale pillar: DGICB posts -3.4% YoY revenue growth and -11.3% YoY earnings growth on $955M TTM revenue (9.2% gross margin, 9.0% operating margin), compared with ROOT at -1.7% YoY revenue growth and +15.5% YoY earnings growth on $1.56B TTM revenue (39.4% gross margin, 6.7% operating margin). On trailing 12-month operating scale, DGICB generates $955M in USD-normalized revenue versus $1.56B for ROOT. In operating R&D and SG&A reinvestment, DGICB deploys N/A (0 90-day corporate R&D disclosures) versus 32.7% of Rev ($510M) (0 disclosures) for ROOT.
DGICB screens cheaper on headline valuation multiples. DGICB trades at 14.4x Forward P/E, 15.2x Trailing P/E, 1.90x PEG, and 1.1x EV/Revenue (9.2% EBITDA margin), whereas ROOT trades at 16.0x Forward P/E, 9.2x Trailing P/E, N/M PEG, and 0.2x EV/Revenue (10.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DGICB (10.7% ROE) versus ROOT (19.9% ROE) capital efficiency.
In options market volatility and institutional positioning, DGICB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.27β · 86% Vol realized risk). By comparison, ROOT carries 62.8% implied volatility (22nd %ile, Compressed (<25th %ile)), a 0.49x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (1.51β · 79% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.